Japan’s Takeda half-year profit climbs, announces share buyback -Breaking
[ad_1]
TOKYO, Reuters – Japan’s Takeda Pharmaceutical Co announced Thursday that it saw a 61% increase in its half-year profits as it tries to make synergies from its acquisition. Shire Plc (LON): The drugmaker reported that operating profit reached 346 billion Japanese yen ($3.05 trillion) for the six-months ending Sept. 30. This is a significant improvement on the 215.6 billion yen last year. Takeda maintained its forecast for full-year operating profits at 488 billion Japanese yen. This compares to the consensus estimate of 509.2 Billion yen, as derived from a Refinitiv poll that included 13 analysts.
Additionally, the company stated it was willing to buy back as much as 2.23% of 100 billion yen-worth shares.
($1 = 113.5700 yen)
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]